Huachansu & Gemcitabine in Pancreatic Cancer
Phase 2
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2009-02-05
- Last Posted Date
- 2012-07-12
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT00837239
- Locations
- π¨π³
Cancer Hospital Fudan University, Shanghai, China
Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.
Completed
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2009-02-05
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 938
- Registration Number
- NCT00837499
- Locations
- πΊπΈ
Arizona Cancer Center, Tucson, Arizona, United States
πΊπΈUniversity of Texas MD Anderson Cancer Center, Houston, Texas, United States
πΊπΈThe Rose Diagnostic Center, Houston, Texas, United States
Questionnaire and Fall Risk Assessment
Completed
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: InterviewOther: Physical Function Tests
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT00836238
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver
Phase 1
Completed
- Conditions
- Liver MetastasisMelanoma
- Interventions
- Drug: Nab-Paclitaxel (Abraxane)
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00833807
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
FDG-PET-CT and Biomarkers in Esophageal Cancer
Not Applicable
Completed
- Conditions
- Gastrointestinal DiseaseEsophageal Cancer
- Interventions
- Procedure: PET/CT (FDG PET/CT)Other: Biomarker Testings
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 31
- Registration Number
- NCT00833625
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)
Phase 1
Completed
- Conditions
- Lung Cancer
- Interventions
- Procedure: EBUS-TBNA
- First Posted Date
- 2009-01-30
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT00832715
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid
Phase 2
Active, not recruiting
- Conditions
- Eyelid Sebaceous Gland Carcinoma
- Interventions
- Procedure: Lymph Node MappingProcedure: Sentinel Lymph Node Biopsy
- First Posted Date
- 2009-01-30
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00832429
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
TKI258 in Castrate Resistant Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- Drug: TK1258
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT00831792
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Vorinostat Plus Radiation Therapy in Pancreatic Cancer
Phase 1
Terminated
- Conditions
- Pancreatic Cancer
- Interventions
- Radiation: Chemoradiation (Radiation Therapy)
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT00831493
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)
Completed
- Conditions
- Breast CancerOvarian Cancer
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 156
- Registration Number
- NCT00829959
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States